KUAN-YIN LINCHIEN-CHING HUNG2021-12-012021-12-0120150269-9370https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964869883&doi=10.1097%2fQAD.0000000000000835&partnerID=40&md5=9f31a235fe7ecb1c48c0fbad7cda9533https://scholars.lib.ntu.edu.tw/handle/123456789/588793[SDGs]SDG3[SDGs]SDG10antihistaminic agent; darunavir; ritonavir; steroid; sulfamethoxazole; trimethoprim; anti human immunodeficiency virus agent; antiinfective agent; cotrimoxazole; darunavir; cross reaction; disease severity; drug hypersensitivity; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Letter; priority journal; rash; adverse drug reaction; Bacterial Infections; complication; drug hypersensitivity; drug interaction; HIV Infections; metabolism; pathology; retrospective study; Anti-Bacterial Agents; Anti-HIV Agents; Bacterial Infections; Darunavir; Drug Hypersensitivity; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combinationletter10.1097/QAD.0000000000000835265445852-s2.0-84964869883